Table 1.
Patient characteristics
| tumor type | PTC ACO |
PTC CG |
p-value | FVPTC ACO |
FVPTC CG |
p-value | FTC ACO |
FTC CG |
p-value | oFTC ACO |
oFTC CG |
p-value | PD | oPD | p-value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | male | 7 | 2 | 0.75 | 4 | 3 | 0.77 | 0 | 2 | 0.27 | 1 | 5 | 0.21 | 4 | 6 | 0.34 |
| female | 13 | 5 | 5 | 5 | 4 | 10 | 3 | 3 | 10 | 7 | ||||||
| Age (mean in years ± Std. Error) | 47.4 ± 3.6 | 48.9 ± 5.5 | 49.2 ± 5.9 | 52.8 ± 6.7 | 42.5 ± 4.6 | 42.7 ± 5.1 | 76.5 ± 0.9 | 60.9 ± 2.7 | 65.4 ± 10.4 | 71.5±9.2 | ||||||
| Tumor stage | pT1 | 2 | 2 | 0.5 | 0 | 1 | 0.18 | 0 | 0 | 0.007 | 0 | 0 | 0.59 | 0 | 0 | 0.098 |
| pT2 | 3 | 0 | 0 | 0 | 3 | 0 | 1 | 1 | 0 | 3 | ||||||
| pT3 | 15 | 5 | 8 | 7 | 1 | 12 | 3 | 7 | 14 | 10 | ||||||
| pT4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| t overall survival (OS) (months ± Std. Error) | 76.9 ± 11.7 | 67.9 ± 10.6 | 73.7 ± 15.7 | 89.0 ± 17.5 | 83.4 ± 22.1 | 114.9 ± 16.3 | 114.8 ± 35.9 | 116.6 ± 19.7 | 70.0 ± 39.6 | 63.4 ± 57.5 | ||||||
| t tumor specific survival (TSS) (months ± Std. Error) | 76.9 ± 11.7 | 67.9 ± 10.6 | 73.7 ± 15.7 | 89.0 ± 17.5 | 83.4 ± 22.1 | 114.9 ± 16.3 | 114.8 ± 35.9 | 119.8 ± 22.4 | 70.0 ± 39.6 | 63.4 ± 57.5 | ||||||
| t relapse free survival (RFS (months ± Std. Error) | 11.0 ± 1.8 | 67.9 ± 10.6 | 26.3 ± 13.3 | 89.1 ± 17.6 | 6.5 ± 1.3 | 114.9 ± 16.3 | 52 ± 34.6 | 119.9 ± 22.4 | 15.8 ± 18.2 | 20.3 ± 22.7 |
PTC = Papillary Thyroid Carcinoma; FVPTC = Follicular Variant of Papillary Thyroid Carcinoma; FTC min. inv. = Minimally Invasive Thyroid Carcinoma; PD = Poorly differentiated Thyroid Carcinoma; oFTC min. inv. = Oncocytic Minimally Invasive Thyroid Carcinoma; oPD = Oncocytic Poorly differentiated Thyroid Carcinoma. ACO = Adverse Clinical Outcome; CG = Control Group